| Literature DB >> 22611352 |
Li Sun1,2, Dongli Li1, Meihua Tao1, Yuchan Chen1, Feijun Dan2, Weimin Zhang1.
Abstract
Five new oxygenated pimarane diterpenes, named scopararanes C-G (1-5) were isolated from the culture of a marine sediment-derived fungus Eutypella scoparia FS26 obtained from the South China Sea. The structures of these compounds were established on the basis of extensive spectroscopic analysis. The absolute configurations of compounds 1-5, were determined by CD spectroscopic analysis and comparison with literature data. All isolated compounds (1-5) were evaluated for their cytotoxic activities against MCF-7, NCI-H460, and SF-268 tumor cell lines by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) method.Entities:
Keywords: pimarane diterpenes; Eutypella scoparia; South China Sea; cytotoxic activity; marine sediment-derived fungus
Mesh:
Substances:
Year: 2012 PMID: 22611352 PMCID: PMC3347013 DOI: 10.3390/md10030539
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Chemical structures of compounds 1–11.
1H and 13C NMR spectroscopic data of compounds 1–3.
| Position | 1 a | 2 a | 3 b | |||
|---|---|---|---|---|---|---|
| δC, mult. | δH (
| δC, mult. | δH (
| δC, mult. | δH (
| |
| 1α | 30.6, CH2 | 1.98, m | 28.8, CH2 | 2.12, ddd (13.0, 13.0, 4.1) | 32.0, CH2 | 2.18, ddd (13.5, 13.5, 4.7) |
| 1β | 1.53, m | 1.59, m | 1.85, ddd (13.5, 4.2, 1.6) | |||
| 2 | 17.7, CH2 | 1.65, 2m | 25.7, CH2 | 1.78, 2m | 26.7, CH2 | 1.74, 2m |
| 3 | 41.4, CH2 | 1.55, m; 1.45, m | 76.8, CH | 3.42, dd (11.4, 4.5) | 77.7, CH | 3.40, dd (11.1, 5.0) |
| 4 | 35.4, C | 40.7, C | 41.8, C | |||
| 5 | 142.8, C | 143.3, C | 145.6, C | |||
| 6 | 144.4, C | 6.73, s (OH) | 145.0, C | 144.9, C | ||
| 7 | 181.6, C | 182.1, C | 183.3, C | |||
| 8 | 133.7, C | 133.8, C | 134.9, C | |||
| 9 | 74.1, C | 73.6, C | 76.1, C | |||
| 10 | 45.1, C | 44.6, C | 46.7, C | |||
| 11α | 25.2, CH2 | 1.81, ddd (12.4, 3.2, 2.4) | 25.5, CH2 | 1.74, m | 65.8, CH | |
| 11β | 1.93, ddd (12.4, 12.4, 3.2) | 2.03, ddd (13.6, 13.6, 3.0) | 4.23, dd (12.1, 4.2) | |||
| 12α | 29.5, CH2 | 1.88, ddd (12.4, 12.4, 3.2) | 29.1, CH2 | 1.92, ddd (13.6, 13.6, 3.0) | 39.9, CH2 | 1.79, m |
| 12β | 1.58, m | 1.59, m | 1.65, ddd (12.1, 4.2, 1.9) | |||
| 13 | 38.8, C | 38.4, C | 40.1, C | |||
| 14 | 147.9, CH | 7.04, d (1.8) | 147.9, CH | 6.95, d (1.8) | 147.0, CH | 6.94, d (1.8) |
| 15 | 145.4, CH | 5.87, dd (17.5, 10.7) | 145.4, CH | 5.94, dd (17.5, 10.7) | 146.1, CH | 5.89, dd (17.5, 10.7) |
| 16a | 112.6, CH2 | 5.10, dd (17.5, 0.7) | 111.3, CH2 | 5.13, dd (17.5, 0.9) | 112.3, CH2 | 5.13, dd (17.5, 0.8) |
| 16b | 5.06, dd (10.7, 0.7) | 5.07, dd (10.7, 0.9) | 5.05, dd (10.7, 0.8) | |||
| 17 | 23.3, CH3 | 1.13, s | 22.3, CH3 | 1.15, s | 24.0, CH3 | 1.18, s |
| 18 | 30.1, CH3 | 1.41, s | 24.9, CH3 | 1.55, s | 25.9, CH3 | 1.54, s |
| 19 | 26.9, CH3 | 1.29, s | 18.1, CH3 | 1.25, s | 19.0, CH3 | 1.21, s |
| 20 | 29.4, CH3 | 1.21, s | 28.7, CH3 | 1.22, s | 29.2, CH3 | 1.24, s |
a Measured in CDCl3; b Measured in CD3OD. 500 MHz for 1H NMR; 125 MHz for 13C NMR.
Figure 2Key HMBC (arrows) and COSY (bold lines) correlations of compound 1.
Figure 3Key NOESY correlations of compounds 1 and 4, whose conformation was modeled by using the MM2 minimum energy calculation [15].
1H and 13C NMR data of compounds 4–5.
| Position | 4 b | 5 a | ||
|---|---|---|---|---|
| δC, mult. | δH (
| δC, mult. | δH (
| |
| 1 | 24.8, CH2 | 1.55, 2m | 29.1, CH2 | 1.63, 2m |
| 2 | 18.9, CH2 | 1.61, 2m | 17.9, CH2 | 1.67, 2m |
| 3 | 38.7, CH2 | 1.64, m; 1.11, m | 36.3, CH2 | 1.71, m; 1.53, m |
| 4 | 37.4, C | 36.7, C | ||
| 5 | 80.0, C | 82.6, C | ||
| 6 | 107.2, C | 210.9, C | ||
| 7 | 74.6, CH | 4.48, s | 74.6, CH | 5.23, s |
| 8 | 132.6, C | 131.8, C | ||
| 9 | 141.7, C | 139.8, C | ||
| 10 | 52.1, C | 50.7, C | ||
| 11α | 21.7, CH2 | 2.19, ddd (13.6, 5.8, 2.9) | 21.2, CH2 | 2.15, m |
| 11β | 1.92, m | 1.90, m | ||
| 12α | 28.0, CH2 | 1.80, m | 30.2, CH2 | 1.83, m |
| 12β | 1.41, m | 1.49, m | ||
| 13 | 39.6, C | 39.7, C | ||
| 14 | 70.6, CH | 4.01, s | 72.4, CH | 4.13, s |
| 15 | 146.2, CH | 6.07, dd (17.5, 11.1) | 142.0, CH | 6.03, dd (17.3, 1.4) |
| 16a | 112.1, CH2 | 5.07, dd (17.5, 1.5) | 114.8, CH2 | 5.23, dd (17.3, 1.4) |
| 16b | 5.05, dd (11.1, 1.5) | 5.21, dd (11.4, 1.4) | ||
| 17 | 21.3, CH3 | 0.93, s | 22.8, CH3 | 1.08, s |
| 18 | 24.3, CH3 | 1.46, s | 23.8, CH3 | 1.46, s |
| 19 | 28.9, CH3 | 1.23, s | 27.8, CH3 | 1.07, s |
| 20 | 72.4, CH2 | 4.13, d (9.2) | 23.5, CH3 | 1.07, s |
| 3.40, d (9.2) | ||||
a Measured in CDCl3; b Measured in CD3OD. 500 MHz for 1H NMR; 125 MHz for 13C NMR.
Cytotoxic activities of compounds 1–11.
| Compounds | IC50 (μM) | ||
|---|---|---|---|
| SF-268 | MCF-7 | NCI-H460 | |
| >100 | 35.9 | >100 | |
| 43.5 | 25.6 | 46.1 | |
| >100 | 74.1 | >100 | |
| >100 | >100 | >100 | |
| >100 | 85.5 | >100 | |
| 20.5 | 12.0 | 40.2 | |
| 80.1 | 60.1 | >100 | |
| >100 | >100 | >100 | |
| 9.2 | 4.4 | 9.9 | |
| >100 | >100 | >100 | |
| >100 | >100 | >100 | |
| 4.0 | 9.2 | 1.5 | |
Data for compounds 6 to 11 were taken from [12].